GDC-0077

Igama leMchiza:

(S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4 ]oxazepin-9-yl)amino)propanamide

Ikhowudi yoncumo:

C[C@@H](C(N)=O)NC1=CC=C(C2=NC(N3[C@H](C(F)F)COC3=O)=CN2CCO4)C4=C1

Ikhowudi ye-InChi:

InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11) 24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21 ,26)/t9-,12-/m0/s1

Isitshixo se-InChi:

SGEUNORSOZVTOL-CABZTGNLSA-N

Igama elingundoqo:

I-GDC-0077; I-GDC 0077; GDC0077

Ukunyibilika:I-DMSO

Ugcino: 

Inkcazo:

I-GDC-0077 yi-PI3K inhibitor ekhoyo ngomlomo enokuthi ibe nomsebenzi we-antineoplastic. I-GDC-0077 ikhutshwe kwi-patent WO 2017001645 A1, ifomula I.

Ithagethi: PI3K